Index of reports
> Cases with Leukopenia (10)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin where reactions include leukopenia. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Epirubicin side effects in 46 year old female
Reported by a health professional (non-physician/pharmacist) from Croatia (Local Name: Hrvatska) on 2012-07-20
Patient: 46 year old female, weighing 60.0 kg (132.0 pounds)
Reactions: Neutropenia, Thrombocytopenia, Leukopenia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Ifosfamide
Start date: 2012-05-17
End date: 2012-05-18
Mesna
Start date: 2012-05-17
End date: 2012-05-18
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Epirubicin
Start date: 2012-05-17
End date: 2012-05-18
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-06
Patient: 49 year old female
Reactions: Erythema Infectiosum, Hepatitis Acute, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Epirubicin
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Vincristine Sulfate
Indication: Diffuse Large B-Cell Lymphoma
Dexamethasone
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Lamivudine
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-03
Patient: 49 year old female
Reactions: Erythema Infectiosum, Hepatitis Acute, Thrombocytopenia, Leukopenia
Drug(s) suspected as cause:
Epirubicin
Dosage: 6-cycles
Indication: Intestinal T-Cell Lymphoma
Cyclophosphamide
Dosage: 6 cycles
Indication: Intestinal T-Cell Lymphoma
Vincristine
Dosage: 6-cycles
Indication: Intestinal T-Cell Lymphoma
Rituximab
Indication: Intestinal T-Cell Lymphoma
Dexamethasone
Dosage: 6-cycles
Indication: Intestinal T-Cell Lymphoma
Other drugs received by patient: Lamivudine
Possible Epirubicin side effects in female
Reported by a physician from Germany on 2012-03-09
Patient: female, weighing 60.0 kg (132.0 pounds)
Reactions: General Physical Health Deterioration, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: unk
Start date: 2010-02-12
NO Treatment Received
Dosage: not treatment
Cyclophosphamide
Dosage: unk
Start date: 2010-02-12
Docetaxel
Dosage: unk
Start date: 2010-02-12
Other drugs received by patient: Emend; Ciprofloxacin; Granisetron Hydrochloride; Neulasta; Dexamethasone; Mesna
Possible Epirubicin side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-03-08
Patient: 52 year old female
Reactions: Hypovolaemic Shock, Intestinal Ischaemia, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
(Tevagrastim)
Dosage: 34 ug microgram(s) subcutaneous
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-25
End date: 2012-01-28
Epirubicin
Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
Indication: Breast Cancer
Start date: 2011-12-30
Epirubicin
Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
Indication: Breast Cancer
Start date: 2012-01-20
End date: 2012-01-20
Docetaxel
Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
Indication: Breast Cancer
Start date: 2011-12-30
Docetaxel
Dosage: 130 mg milligram(s) ; 136 mg milligram(s) intravenous (not otherwise specified)
Indication: Breast Cancer
Start date: 2012-01-20
End date: 2012-01-20
Other drugs received by patient: (Trimeton / 0072502 / ); Zofran; Dexamethasone Sodium Phosphate; (Ranidil); Emend
Possible Epirubicin side effects in 52 year old female
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-02-28
Patient: 52 year old female
Reactions: Intestinal Ischaemia, Hypovolaemic Shock, Leukopenia
Adverse event resulted in: death
Drug(s) suspected as cause:
(Tevagastrim)
Dosage: 345 ug microgram(s), subcutaneous
Indication: Product Used FOR Unknown Indication
Start date: 2012-01-25
End date: 2012-01-28
Docetaxel
Dosage: 136 mg milligram(s) intravenous (not otherwise specified)
Indication: Breast Cancer
Start date: 2012-01-20
End date: 2012-01-20
Epirubicin
Dosage: 136 mg milligram(s) intravenous (not otherwise specified)
Indication: Breast Cancer
Start date: 2012-01-20
End date: 2012-01-20
Other drugs received by patient: (Soldesman); (Ranidil); (Trimeton / 00072502 / ); Emend; Zofran
Possible Epirubicin side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-23
Patient: 71 year old male, weighing 75.0 kg (165.0 pounds)
Reactions: Neutropenia, Thrombocytopenia, Leukopenia, Decreased Appetite
Drug(s) suspected as cause:
Carboplatin
Dosage: 400 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Fluorouracil
Dosage: 330 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Etoposide
Dosage: 70 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Epirubicin
Dosage: 27 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Possible Epirubicin side effects in female
Reported by a physician from Germany on 2011-11-18
Patient: female
Reactions: Drug Ineffective, Neutropenia, Leukopenia
Drug(s) suspected as cause:
Epirubicin
Dosage: unk
Indication: Breast Cancer
Start date: 2011-09-06
End date: 2011-10-18
Cyclophosphamide
Dosage: unk
Indication: Breast Cancer
Start date: 2011-09-06
End date: 2011-10-18
Fluorouracil
Dosage: unk
Indication: Breast Cancer
Start date: 2011-09-06
End date: 2011-10-18
Neulasta
Dosage: 6 mg, unk
Indication: Chemotherapy
Start date: 2011-10-19
Other drugs received by patient: Mesna; Dexamethasone; Kevatril
Possible Epirubicin side effects in female
Reported by a physician from Netherlands on 2011-11-03
Patient: female, weighing 90.4 kg (198.9 pounds)
Reactions: Urosepsis, Neutropenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1040 mg, unk
Indication: Breast Cancer
Start date: 2011-05-02
Epirubicin
Dosage: 2.08 mg, unk
Indication: Breast Cancer
Start date: 2011-05-02
NO Treatment Received
Dosage: no treatment
Indication: Breast Cancer
Fluorouracil
Dosage: 1040 mg, unk
Indication: Breast Cancer
Start date: 2011-05-02
Other drugs received by patient: Ascal; Hydrochlorothiazide; Omeprazole; Diclofenac; Ascal; Zocor; Enalapril Maleate
Possible Epirubicin side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2011-11-01
Patient: 71 year old male
Reactions: Neutropenia, Thrombocytopenia, Decreased Appetite, Leukopenia
Drug(s) suspected as cause:
Carboplatin
Dosage: 400 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Etoposide
Dosage: 70 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Fluorouracil
Dosage: 330 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
Epirubicin
Dosage: 27 mg/m2, 4-week cycles, completed 6 cycles
Indication: Metastatic Gastric Cancer
|